Pelgifatamab (BAY-2315497) is a monoclonal antibody targeting the prostate-specific membrane antigen (PSMA). This antibody can be covalently attached to a 225Ac binding moiety, making it a valuable tool for research into metastatic castration-resistant prostate cancer (mCRPC). Pelgifatamab's specificity for PSMA and its potential for radioisotope conjugation facilitate its use in advanced prostate cancer studies, particularly in therapeutic research and radiolabeled imaging applications.
Pelgifatamab (BAY-2315497) is a monoclonal antibody targeting the prostate-specific membrane antigen (PSMA). This antibody can be covalently attached to a 225Ac binding moiety, making it a valuable tool for research into metastatic castration-resistant prostate cancer (mCRPC). Pelgifatamab's specificity for PSMA and its potential for radioisotope conjugation facilitate its use in advanced prostate cancer studies, particularly in therapeutic research and radiolabeled imaging applications.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
